Proximal Tubular Secretion of Creatinine by Organic Cation Transporter OCT2 in Cancer PatientsGiuliano Ciarimboli, Alex Sparreboom, Cynthia S. Lancaster et al.|Clinical Cancer Research|2012Cited by 164
The calcium-activated chloride channel Anoctamin 1 contributes to the regulation of renal functionDiana Faria, Rainer Schreiber, Karl Kunzelmann et al.|Kidney International|2014Cited by 74
Everolimus in metastatic renal cell carcinoma after failure of initial anti–VEGF therapy: final results of a noninterventional studyLothar Bergmann, Michael Staehler, Ulrich Kube et al.|BMC Cancer|2015Cited by 23
Everolimus in Metastatic Renal Cell Carcinoma after Failure of Initial Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitor (VEGFr-TKI) Therapy: Results of an Interim Analysis of a Non-Interventional StudyLothar Bergmann, Christian Doehn, Peter J. Goebell et al.|Oncology Research and Treatment|2013Cited by 15
Temsirolimus in Daily Use: Results of a Prospective Multicentre Noninterventional Study of Patients with Metastatic Kidney CancerAndres Jan Schrader, Thomas Steiner, S. Seseke et al.|European Urology|2013Cited by 12